In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Canary in the coalmine stuff here?
The advisers stand to benefit if the sector sees more deal activity under Trump.
Doug Kass shares his thoughts on biotech, and discusses the shape of things to come.
The company is lagging.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.